• BioSyent CEO René Goehrum disclosed peak beneficial ownership of 20.22% as of Nov. 6, 2026, in a historical ownership report.
• His holdings included 2,244,982 common shares and 33,301 stock options exercisable within 60 days.
• Beneficial ownership stood at 12.81% on Jan. 4, 1996, when he first triggered early warning reporting requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioSyent Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100700PRIMZONEFULLFEED9873760) on November 10, 2026, and is solely responsible for the information contained therein.